Table 2.
Univariable Cox proportional hazard regression models with Benjamini-Hochberg false discovery rate (FDR) adjustment
Local recurrence |
Regional recurrence |
Distant recurrence |
Overall survival |
||||||
---|---|---|---|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | FDR | HR (95% CI) | P | |
Clinical factors | |||||||||
Age | 0.99 (0.95-1.04) | .77 | 0.97 (0.93-1.01) | .12 | 0.99 (0.95-1.03) | .56 | 0.81 | 1.03 (0.99-1.06) | .10 |
T stage | 0.55 (0.20-1.49) | .24 | 1.09 (0.66-1.78) | .74 | 0.78 (0.37-1.61) | .49 | 0.81 | 1.09 (0.63-1.90) | .75 |
Treatment factors | |||||||||
BED | 1.00 (0.99-1.01) | .98 | 1.00 (0.99-1.01) | .89 | 1.00 (0.99-1.01) | .99 | 0.99 | 1.00 (0.99-1.01) | .51 |
GTV | 0.99 (0.97-1.02) | .53 | 0.99 (0.97-1.01) | .35 | 0.98 (0.96-1.00) | .03 | 0.11 | 1.00 (0.98-1.01) | .51 |
Imaging metrics | |||||||||
SUVDx | 1.04 (0.98-1.11) | .20 | 1.04 (0.99-1.09) | .15 | 1.02 (0.96-1.08) | .52 | 0.81 | 1.01 (0.97-1.06) | .61 |
SUVSim | 1.04 (0.99-1.10) | .15 | 1.05 (1.00-1.10) | .06 | 1.01 (0.96-1.08) | .65 | 0.65 | 1.03 (0.99-1.08) | .12 |
MTVDx | 0.99 (0.95-1.04) | .69 | 0.99 (0.95-1.02) | .43 | 0.95 (0.90-0.99) | .02 | 0.11 | 0.99 (0.97-1.02) | .62 |
MTVSim | 0.99 (0.96-1.02) | .47 | 0.99 (0.97-1.01) | .27 | 0.97 (0.95-1.00) | .03 | 0.11 | 1.00 (0.99-1.01) | .61 |
SUVV | 12.36 (0.38-404.55) | .16 | 4.34 (0.44-42.42) | .21 | 4.00 (0.38-42.57) | .25 | 0.63 | 11.8 (0.85-165.1) | .07 |
MTGR | 0.63 (0.13-2.99) | .56 | 0.51 (0.14-1.93) | .32 | 0.78 (0.18-3.33) | .73 | 0.73 | 1.07 (0.29-3.94) | .91 |
Abbreviations: BED = biologically effective dose; CI = confidence interval; Dx = at diagnosis; GTV = gross tumor volume; HR = hazard ratio; MTGR = metabolic tumor growth rate; MTV = metabolic tumor volume; PET/CT = positron emission tomography with computed tomography; Sim = at simulation; SUV = standardized uptake value; SUVV = SUV velocity.
P-values less than 0.05 are bolded.